The importance of obesity in diabetes and its treatment with sibutramine

International Journal of Obesity

Volumn 25, Issue , 2001, Pages S24-S28

  Van Gaal, L F ^a   Peiffer, F W ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Glycaemic control; HbA1c; Sibutramine; Type 2 diabetes; Waist

Indexed keywords

HEMOGLOBIN A1C; SIBUTRAMINE;

BODY WEIGHT; CLINICAL TRIAL; COMORBIDITY; CONFERENCE PAPER; DIABETIC OBESITY; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK FACTOR; WEIGHT GAIN; WEIGHT REDUCTION;

APPETITE DEPRESSANTS; CYCLOBUTANES; DIABETES MELLITUS, TYPE 2; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; OBESITY; WEIGHT LOSS;

EID: 0035702916     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/sj.ijo.0801935     Document Type: Article

References (16)

1. WHO. Obesity; preventing and managing the global epidemic. Report of a WHO consultation on obesity, Geneva, 3-5 June 1997. WHO: Geneva; 1998.Gallup, November 1996.
2. Ohlson LO, Ohlson LO, Larsson B, Svardsudd K, Welin L, Eriksson H, Wilhelmsen L, Bjorntorp P, Tibblin G. The influence of body fat distribution on the incidence of diabetes mellitus. Diabetes 1985; 34: 1055-1058.
3. Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 1994; 17: 961-969.
4. Colditz GA, Willett WC, Rotnitzky A, Manson JF. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 1995; 122: 481-486.
5. Wolf AM. What is the economic case for treating obesity? Obes Res 1998; 6(Suppl 1): 2S-7S.
6. Mooy JM, Grootenhuis PA, de Vries H et al. Prevalence and determinants of glucose intolerance in a Dutch Caucasian population: the Hoorn Study. Diabetes Care 1995; 18: 1270-1273.
7. Wing RR, Venditti E, Jakicic JM, Polley BA, Lang W. Lifestyle intervention in overweight individuals with a family history of diabetes. Diabetes Care 1998; 21: 350-359.
8. Moore LL, Visioni AJ, Wilson PW, D'Agostino RB, Finkle WD, Ellison RC. Can sustained weight loss in overweight individuals reduce the risk of diabetes mellitus? Epidemiology 2000; 11: 269- 273.
9. Tuomilehto J, Lindstrom J, Eriksson JG et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. New Engl/Med 2001; 344: 1343- 1350.
10. Wing RR, Marcus MD, Epstein LH, Salata R. Type II diabetic subjects lose less weight than their overweight nondiabetic spouses. Diabetes Care 1987; 10: 563-566.
11. Turner R, Cull C, Holman R. United Kingdom Prospective Diabetes Study: a 9-year update of a randomized controlled trial on the effect of improved metabolic control on complications in non-insulin dependent diabetes mellitus. Ann Intern Med 1996; 124: 136-145.
12. Goldstein DJ. Beneficial health effects of modest weight loss. Int J Obes Relat Metab Disord 1992; 16: 397-415.
13. Van Gaal LF, Wauters MW, De Leeuw IH. The beneficial effects of modest weight loss on cardiovascular risk factors. Int/Obes Relat Metab Disord 1997; 21(Suppl 1): S5-S9.
14. Williamson DF, Pamuk E, Thun M, Flanders D, Byers T, Heath C. Prospective study of intentional weight loss and mortality in never-smoking overweight US white women aged 40-64y. Am/Epidemiol 1995; 141: 1128-1141.
15. Lean MEJ, Powrie JK, Anderson AS, Garthwaite PH. Obesity, weight loss and prognosis in type 2 diabetes. Diabetic Med 1990; 7: 228-233.
16. Lauterbach, K, Evers T. Weight loss on sibutramine treatment reduces risk of coronary heart disease in obese subjects. Circulation 2000; 18(Suppl 2).